# Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation

> **NCT03076151** · PHASE4 · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 30 (actual)

## Conditions studied

- Transplantation
- Kidney
- Pharmacokinetic

## Interventions

- **DRUG:** Tacrolimus monohydrate (ADOPORT®)

## Key facts

- **NCT ID:** NCT03076151
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-12
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03076151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03076151, "Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03076151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*